In last trading session, Acelyrin Inc (NASDAQ:SLRN) saw 1.09 million shares changing hands with its beta currently measuring 2.25. Company’s recent per share price level of $6.08 trading at $0.36 or 6.29% at ring of the bell on the day assigns it a market valuation of $606.84M. That closing price of SLRN’s stock is at a discount of -75.99% from its 52-week high price of $10.70 and is indicating a premium of 44.74% from its 52-week low price of $3.36. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.53 million shares which gives us an average trading volume of 1.07 million if we extend that period to 3-months.
For Acelyrin Inc (SLRN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.86. Splitting up the data highlights that, out of 14 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 5 suggested the stock as a Hold whereas 9 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.8 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Acelyrin Inc (NASDAQ:SLRN) trade information
Upright in the green during last session for gaining 6.29%, in the last five days SLRN remained trading in the green while hitting it’s week-highest on Wednesday, 10/16/24 when the stock touched $6.08 price level, adding 0.33% to its value on the day. Acelyrin Inc’s shares saw a change of -18.50% in year-to-date performance and have moved 28.27% in past 5-day. Acelyrin Inc (NASDAQ:SLRN) showed a performance of 38.81% in past 30-days. Number of shares sold short was 6.39 million shares which calculate 6.7 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10.5 to the stock, which implies a rise of 42.1% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 15. It follows that stock’s current price would jump 1.32% in reaching the projected high whereas dropping to the targeted low would mean a gain of 1.32% for stock’s current value.
Acelyrin Inc (SLRN) estimates and forecasts
Statistics highlight that Acelyrin Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 21.12% of value to its shares in past 6 months, showing an annual growth rate of 43.28% while that of industry is 17.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Acelyrin Inc (NASDAQ:SLRN)’s Major holders
Insiders are in possession of 8.07% of company’s total shares while institution are holding 106.79 percent of that, with stock having share float percentage of 116.17%. Investors also watch the number of corporate investors in a company very closely, which is 106.79% institutions for Acelyrin Inc that are currently holding shares of the company.
